Chien-Wei Su Selected Research

Nivolumab

1/2022

Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chien-Wei Su Research Topics

Disease

69	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2008
56	Neoplasms (Cancer) 01/2024 - 11/2009
22	Chronic Hepatitis B 12/2023 - 11/2008
21	Fibrosis (Cirrhosis) 01/2024 - 10/2009
15	Liver Neoplasms (Liver Cancer) 01/2024 - 06/2010
13	Ascites 01/2023 - 01/2010
12	Infections 02/2024 - 05/2007
10	Chronic Hepatitis C 01/2024 - 01/2017
10	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2010
10	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 03/2011
8	Hepatitis B 01/2023 - 01/2008
7	Liver Diseases (Liver Disease) 11/2023 - 11/2002
7	End Stage Liver Disease 10/2023 - 07/2008
5	Hepatitis 12/2023 - 11/2002
5	Disease Progression 02/2022 - 03/2011
5	Hemorrhage 12/2012 - 10/2009
4	Inflammation (Inflammations) 12/2023 - 10/2011
4	Esophageal and Gastric Varices (Esophageal Varices) 01/2018 - 06/2010
4	Fatty Liver 01/2017 - 01/2013
3	Renal Insufficiency (Renal Failure) 11/2023 - 09/2010
3	Acute Kidney Injury (Acute Renal Failure) 12/2018 - 01/2010
3	Chronic Hepatitis D 04/2009 - 05/2007
2	Sepsis (Septicemia) 01/2022 - 01/2020
2	Thrombocytopenia (Thrombopenia) 08/2021 - 10/2020
2	Hepatitis C 01/2021 - 03/2016
2	Liver Failure 02/2020 - 01/2020
2	Hepatic Encephalopathy 01/2020 - 01/2014
2	Pruritus (Itching) 03/2019 - 01/2008
2	Fatigue 03/2019 - 02/2019
2	Diabetes Mellitus 01/2018 - 10/2015
2	Splenomegaly 06/2017 - 10/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 03/2015
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2009 - 01/2008
1	Genomic Instability 12/2023
1	Hypoalbuminemia 09/2022
1	Neutropenia 02/2022
1	Rupture 01/2022

Drug/Important Bio-Agent (IBA)

33	AlbuminsIBA 01/2024 - 12/2011
32	BilirubinIBA 01/2024 - 01/2014
19	Antiviral Agents (Antivirals)IBA 01/2024 - 09/2010
19	Fetal Proteins (Fetoprotein)IBA 11/2023 - 05/2011
16	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2022 - 01/2008
15	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2024 - 01/2010
14	InterferonsIBA 01/2024 - 01/2011
11	Alanine Transaminase (SGPT)IBA 12/2023 - 10/2009
10	Hepatitis B e AntigensIBA 02/2024 - 06/2010
9	CreatinineIBA 03/2023 - 10/2012
8	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 03/2008
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2010
7	Sorafenib (BAY 43-9006)FDA Link 11/2022 - 03/2015
7	Ribavirin (Virazole)FDA LinkGeneric 03/2021 - 01/2015
7	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 10/2009
7	Serum AlbuminIBA 12/2018 - 01/2012
6	Cytidine Triphosphate (CTP)IBA 10/2023 - 07/2010
5	SodiumIBA 11/2017 - 01/2010
4	entecavir FDA Link 01/2023 - 11/2008
4	RNA (Ribonucleic Acid)IBA 09/2019 - 03/2008
3	CholesterolIBA 12/2023 - 01/2013
3	Tenofovir (Viread)FDA Link 01/2023 - 12/2018
3	peginterferon alfa-2a (Pegasys)FDA Link 09/2021 - 01/2013
3	EnzymesIBA 01/2021 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 02/2022
2	SofosbuvirIBA 01/2022 - 09/2019
2	Hepatitis delta Antigens (HDAg)IBA 05/2020 - 05/2007
2	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 03/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 12/2016
2	daclatasvirIBA 09/2019 - 02/2019
2	AntigensIBA 12/2016 - 06/2010
2	Alkaline PhosphataseIBA 03/2016 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 03/2015 - 01/2015
2	Lamivudine (Epivir)FDA Link 12/2013 - 11/2008
2	Contrast MediaIBA 09/2010 - 01/2010
2	EpitopesIBA 04/2009 - 05/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	Free RadicalsIBA 12/2023
1	Tumor Biomarkers (Tumor Markers)IBA 07/2023
1	atezolizumabIBA 12/2022
1	Bevacizumab (Avastin)FDA Link 12/2022
1	Phosphotransferases (Kinase)IBA 11/2022
1	lenvatinibIBA 10/2022
1	tenofovir alafenamideIBA 09/2022
1	Dacarbazine (DIC)FDA LinkGeneric 02/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	Gemcitabine FDA Link 02/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2022
1	Hydralazine (Apresoline)FDA LinkGeneric 02/2022
1	regorafenibIBA 01/2022
1	NivolumabIBA 01/2022

Therapy/Procedure

45	Therapeutics 02/2024 - 11/2002
17	Radiofrequency Ablation 09/2022 - 01/2008
8	Surgical Instruments (Clip) 04/2021 - 06/2010
4	Drug Therapy (Chemotherapy) 09/2022 - 12/2018
4	Liver Transplantation 01/2019 - 07/2008
2	Injections 02/2024 - 12/2020
2	Aftercare (After-Treatment) 01/2024 - 01/2018
2	Contraindications 01/2022 - 01/2017
2	Retreatment 02/2020 - 11/2015
2	Blood Transfusion (Blood Transfusions) 11/2017 - 11/2002
1	Hepatectomy 01/2023